| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/1998 | US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide |
| 06/23/1998 | US5770559 Promoting the inhalation drug delivery by forming solid particles from a slurries comprising a complexes of active drug with amphiphilic material |
| 06/23/1998 | US5770444 Growth differentiation factor-6 |
| 06/23/1998 | US5770234 Particle induced amplification of immune response |
| 06/23/1998 | US5770233 Container filled with infusion liquids and infusion preparation |
| 06/23/1998 | US5770231 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles |
| 06/23/1998 | US5770230 Method for preparing stabilized prostaglandin E1 |
| 06/23/1998 | US5770227 Progesterone replacement therapy |
| 06/23/1998 | US5770226 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 06/23/1998 | US5770225 Compressing, applying subcoating of castor oil andhydroxypropylmethylcellulose, dipping in gelatinous solution |
| 06/23/1998 | US5770224 Capsule construction |
| 06/23/1998 | US5770223 Topical application of mixtures of plant extracts containing saponins(or derivatives) |
| 06/23/1998 | US5770222 Therapeutic drug delivery systems |
| 06/23/1998 | US5770221 High and low molecular weight polyisobutylene |
| 06/23/1998 | US5770220 Active substance-containing patch |
| 06/23/1998 | US5770219 Solid matrix system for transdermal drug delivery |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | US5770182 Methods for treating teeth with anticariogenic and antimicrobial dental compositions |
| 06/23/1998 | US5770181 Useful for magnetic resonance imaging and tomogrphy; consists of perfluorocarbon contrast agent, bicarbonate gas generating agent, flavor enhancing agent, a drug and a bioactive agent |
| 06/23/1998 | US5770105 Mixing carboxypolymethylene, one or more polyols and water to form a matrix, adding base to adjust ph, dispersing bleaching agent in matrix |
| 06/23/1998 | US5770076 Micromachined capsules having porous membranes and bulk supports |
| 06/23/1998 | US5769895 Delivery system for biologically active growth or morphogenetic factors and a method for preparing such a delivery system |
| 06/23/1998 | US5769088 Process and kits for diagnosing erectile dysfunction, and related methods of treatment |
| 06/23/1998 | US5769080 Gas filled liposomes and stabilized gas bubbles and their use as ultrasonic contrast agents |
| 06/23/1998 | CA2166296C Stabilized pharmaceutical peptide compositions |
| 06/23/1998 | CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives |
| 06/23/1998 | CA2095721C Gel type compositions having improved oil control |
| 06/23/1998 | CA2056384C Bioerodible polymers for drug delivery in bone |
| 06/23/1998 | CA2008739C Compositions and method for the treatment of disease |
| 06/18/1998 | WO1998026008A1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 06/18/1998 | WO1998025655A2 Method and apparatus for administration of substances by ultrasound |
| 06/18/1998 | WO1998025649A1 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 06/18/1998 | WO1998025642A2 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery |
| 06/18/1998 | WO1998025638A1 Use of plant extract for inhibition of haemophilus influenzae |
| 06/18/1998 | WO1998025629A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases |
| 06/18/1998 | WO1998025621A1 Improved pharmaceutical compositions |
| 06/18/1998 | WO1998025620A1 Process for manufacturing ophthalmic suspensions |
| 06/18/1998 | WO1998025613A2 Galenic composition containing opioid antagonists |
| 06/18/1998 | WO1998025599A1 An oil composition of dihydropolyprenols |
| 06/18/1998 | WO1998025595A2 Aqueous drink composition comprising ibuprofen |
| 06/18/1998 | WO1998025592A1 Transdermal preparation containing serotonin receptor antagonist |
| 06/18/1998 | WO1998025591A1 Transdermal drug delivery system for the treatment of heart diseases |
| 06/18/1998 | WO1998025590A2 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance |
| 06/18/1998 | WO1998025589A1 Active agent transport systems |
| 06/18/1998 | WO1998025588A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 06/18/1998 | WO1998013385A3 Non-naturally occurring lipoprotein particle |
| 06/18/1998 | WO1998013024A3 Hyaluronic drug delivery system |
| 06/18/1998 | WO1998010752A3 Process for producing solid dosage forms by extrusion |
| 06/18/1998 | DE19652269A1 Konturen -TTs Contours -TTs |
| 06/18/1998 | DE19652268A1 Wirkstoffträger für die Freisetzung von Apomorphin in der Mundhöhle Drug carrier for release of apomorphine in the oral cavity |
| 06/18/1998 | DE19652257A1 Einzeln dosierte, bei Kontakt mit Flüssigkeit schnell zerfallende, wirkstoff- und insbesondere aromastoffhaltige, folienförmige Darreichnungsform Single-dose, when in contact with liquid rapidly disintegrating, and in particular active ingredient-aromatic-based sheet-shaped Darreichnungsform |
| 06/18/1998 | DE19652196A1 Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen Homogeneous steroid preformulations for producing low-dose solid and semi-solid pharmaceutical preparations |
| 06/18/1998 | DE19652188A1 Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung Flat pharmaceutical preparation for application and release of buprenorphine or a pharmacologically similar substance in the oral cavity and processes for their preparation |
| 06/18/1998 | DE19651681A1 Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthopyllen, deren Herstellung und Verwendung Stable, aqueous dispersions and stable, water-dispersible dry powder of Xanthopyllen, their preparation and use |
| 06/18/1998 | DE19651551A1 Opioidantagonisthaltige galenische Formulierung Opioid antagonist-containing pharmaceutical formulation |
| 06/18/1998 | CA2274847A1 Pharmaceutical formulations for sustained drug delivery |
| 06/18/1998 | CA2274839A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 06/18/1998 | CA2274832A1 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance |
| 06/18/1998 | CA2274690A1 Method and apparatus for administration of substances by ultrasound |
| 06/18/1998 | CA2274111A1 Transdermal preparation containing serotonin receptor antagonist |
| 06/18/1998 | CA2269680A1 An oil composition of dihydropolyprenols |
| 06/17/1998 | EP0847757A1 Medicine comprising hgf gene |
| 06/17/1998 | EP0847277A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 06/17/1998 | EP0847274A1 Adhesive patch for lithium controlled release |
| 06/17/1998 | EP0847273A2 Improved pharmaceutical ion exchange resin composition |
| 06/17/1998 | EP0847272A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 06/17/1998 | EP0847242A1 Sugar-free dragee-like products |
| 06/17/1998 | EP0847239A2 Improved method for controlling ectoparasites |
| 06/17/1998 | EP0768859B1 Controlled release device |
| 06/17/1998 | EP0714415B1 Aqueous copolymer dispersions |
| 06/17/1998 | EP0684814B1 Compositions for oral delivery of active agents |
| 06/17/1998 | EP0616802B1 Oral preparation for release in lower digestive tracts |
| 06/17/1998 | CN1185118A Medical device adhering to the skin |
| 06/17/1998 | CN1185109A Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 06/17/1998 | CN1185107A Pharmaceutical composition contg. proton pump inhititors |
| 06/17/1998 | CN1185105A Novel pharmaceutical pellet formulation |
| 06/17/1998 | CN1185104A Diltiazem controlled release formulation |
| 06/17/1998 | CN1185103A Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal |
| 06/17/1998 | CN1184669A Oral liquor for treating angiocardiopathy and process for preparing same |
| 06/17/1998 | CN1184666A Emplastrum for lowering blood viscosity |
| 06/17/1998 | CN1184665A Emplastrum for preventing and treating coronary heart disease |
| 06/17/1998 | CN1184655A Drug for treating rheumatoid disease |
| 06/17/1998 | CN1184650A External application plaster for preventing and treating bronchial asthma and bronchitis |
| 06/17/1998 | CN1184642A Pill for treating hepatitis and ascites due to liven cirrhosis, and method for preparing same |
| 06/17/1998 | CN1184634A Omega -3 capsule and method for preparing same |
| 06/17/1998 | CN1184632A Method for making sticking film for improving sexual function |
| 06/17/1998 | CN1038727C Method for preparing plaster for treating allergic rhinitis |
| 06/17/1998 | CN1038726C Analgin nasal drops |
| 06/16/1998 | US5767298 Aminophospholipid compositions and uses thereof |
| 06/16/1998 | US5767246 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 06/16/1998 | US5767161 Ibuprofen, ethanol, propylene glycol |
| 06/16/1998 | US5767160 Method and formulation of stimulating nitric oxide synthesis |
| 06/16/1998 | US5767159 Improving the capacity of muscles for work and shortening the time for recovery after exercise or various therapies, e.g.postoperative surgery, respiratory disorders |
| 06/16/1998 | US5767153 Sustained release emulsions |
| 06/16/1998 | US5767143 Eye drops containing single polymer, pilocarpine, beta-blocking agent, carrier, having specified ph and viscosity |
| 06/16/1998 | US5767123 Total parenteral nutrition solution containing water-soluble vitamin B |
| 06/16/1998 | US5767112 Acidic mixture for injection comprising neuromuscular blocking agent and zwitterion having isoelectric point greater than 7; shelf life, anesthetic |
| 06/16/1998 | US5767107 Compositions containing gluten and polysaccharides that contain uronic acid residues useful for encapsulating fats, oils and solids |
| 06/16/1998 | US5767099 Containing lipophilic groups derived from steroids |
| 06/16/1998 | US5767095 Algicide |